- This event has passed.
Hybrid ILS “Toward Precision Medicine for Prostate Cancer”
March 26 @ 11:00 am - 12:30 pm
This session highlights emerging innovations in prostate cancer care—from improving access to services to advances in omics‑driven drug discovery, molecular pathology, ctDNA, and immunometabolomics. Together, these developments are reshaping how treatment decisions are made.
Location: (In – person) Tupper Medical Building, Room 2L-07
Virtual Attendance: click here to attend virtually